December 3, 2008UPDATE 2-Pozen pain drug meets main goal in late-stage trial - Reuters UPDATE 2-Pozen pain drug meets main goal in late-stage trial - Reuters
BANGALORE, Dec 3 (Reuters) - Pharmaceutical company Pozen Inc (POZN.O: Quote , Profile , Research , Stock Buzz ) said its experimental pain drug for arthritis, PN 400, met the main goal of a late-stage trial. The trial's main goal, which is currently Source: www.reuters.com # posted by Network @ 11:00 AM
 |
Subscribe to Posts [Atom]